Manulife (Manufacturers Life Insurance)’s Fibrocell Science Inc. FCSC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-109
Closed -$2K 4412
2017
Q2
$2K Sell
109
-10
-8% -$123 ﹤0.01% 4162
2017
Q1
$1K Hold
119
﹤0.01% 4140
2016
Q4
$1K Hold
119
﹤0.01% 4283
2016
Q3
$1K Hold
119
﹤0.01% 4228
2016
Q2
$2K Sell
119
-806
-87% -$25.1K ﹤0.01% 4045
2016
Q1
$32K Sell
925
-232
-20% -$9.26K ﹤0.01% 3401
2015
Q4
$79 Hold
1,157
﹤0.01% 3158
2015
Q3
$67 Buy
1,157
+1,137
+5,685% +$101K ﹤0.01% 3263
2015
Q2
$2 Buy
+20
New +$1.35K ﹤0.01% 3844
2014
Q2
Sell
-811
Closed -$64 3913
2014
Q1
$64 Buy
+811
New +$62.9K ﹤0.01% 3179

Other funds holding FCSC

Manulife (Manufacturers Life Insurance)'s FCSC Position: Q3 2017 in Review

Manulife (Manufacturers Life Insurance) sold out of Fibrocell Science Inc. (FCSC) in Q3 2017, closing a stake of 109 shares — an estimated $2K sold.

Manulife (Manufacturers Life Insurance) first reported a position in FCSC in Q1 2014 and held it in 10 quarters. The position peaked at $32K in Q1 2016. 32 funds tracked by Wall St. Rank hold FCSC as of Q3 2017.

  • Manulife (Manufacturers Life Insurance) reported no remaining Fibrocell Science Inc. position as of Q3 2017 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 109 Fibrocell Science Inc. shares in Q3 2017, an estimated $2K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Fibrocell Science Inc. in Q1 2014 and held it in 10 quarters.
  • Manulife (Manufacturers Life Insurance)'s Fibrocell Science Inc. position peaked at $32K in Q1 2016.
  • 32 funds tracked by Wall St. Rank held Fibrocell Science Inc. as of Q3 2017.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q3 2017, filed 14 Nov 2017.